Dartmouth researchers convert a standard linear accelerator used for delivery of radiation therapy cancer treatment, to deliver an ultra-high-dose rate radiation therapy beam to patients “in a flash.”
Post Tagged with: "Thayer"
Dartmouth SYNERGY Clinical and Translational Science Institute has appointed Richard J. Barth, Jr., MD, as the first recipient of its SYNERGY Clinician-Entrepreneur Fellowship (S-CEF). The S-CEF will provide Dr. Barth with resources and dedicated time to develop and study the commercial potential of a new system to improve certain types of breast cancer surgery.
A unique facility for both patient care and translational research, the new Center for Surgical Innovation at Dartmouth-Hitchcock combines interoperative imaging capabilities that give surgeons unprecedented ability to see, in real time, the tissue and organs involved in procedures.
Dartmouth researchers have developed a fluorescence imaging technique that can more accurately identify receptors for targeted cancer therapies without a tissue biopsy.
Using CT scans with contrast enhancement, Dartmouth researchers measured treatment response to pancreatic cancerphotodynamic therapy (PDT) according to a paper published in Physics in Medicine and Biology.